Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants
Clinical trial NCT00429481 · COMPLETED
Trial details
- NCT number
- NCT00429481
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2003-04-01
- Enrollment
- 2464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.